Ilias Kounis
Ilias Kounis is an expert in Hepatology at Centre Hépato-Biliaire (France). Ilias Kounis has authored 53 publications, the most recent in 2026, and is an investigator in 3 clinical trials, 2 of them ongoing. SLR score: 220 (community average: 125). How the SLR is computed.
LeadR Profile
Hepatology
Subspecialties: Transplantation - Gastroenterology - Surgery
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 2018 - 2026
Number : 53
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Everolimus and de novo malignancies after liver transplantation: a Nationwide Emulated Trial Using Real-World Data. PMID 42413767 — liver transplantation, incidence, neoplasms, tacrolimus, liver, everolimus, transplants, research, immunosuppression therapy, transplantation | JHEP Rep | 2026 | 0 |
| Immune Checkpoint Inhibitors after liver transplantation: the role of immunosuppressive management. PMID 41720193 — liver transplantation, liver, immune checkpoint inhibitors, transplants, transplantation | Am J Transplant | 2026 | 0 |
| Explainable Mortality Prediction for Liver Transplant Candidates with Hepatocellular Carcinoma: A Supervised Clustering Approach. PMID 41536859 — liver transplantation, mortality, carcinoma, hepatocellular, risk assessment, liver, work, cluster analysis, risk factors, transplants | Health Data Sci | 2026 | 1 |
| Explainable machine learning for prognostic modeling of waitlist mortality in cirrhotic liver transplantation. PMID 41459586 — liver transplantation, mortality, liver, machine learning, risk factors, learning, transplantation | Comput Struct Biotechnol J | 2025 | 0 |
| Donor HLA Class I Evolutionary Divergence and Late Allograft Rejection After Liver Transplantation in Children: An Emulated Target Trial. PMID 40667760 — graft rejection, liver transplantation, biopsy, liver, hla antigens, alleles, transplants, allografts, transplantation, child | HLA | 2025 | 0 |
Clinical Studies 3
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Cohort/Consortium Investigators 1
Ongoing Clinical Trials
2 ongoing trials started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| Portal hypertension in cirrhosis 2023-508535-32-00 — hypertension, venous pressure, hypertension, portal, metformin | Phase 2 | Recruiting | 2025 |
| Effect of Long term Carvedilol to Prevent Decompensation or Death in Patients With Asymptomatic Child Pugh A5 to B8 Cirrhosis and Clinically Significant Portal Hypertension a Multicenter Double blind Randomized Control Trial NCT06263816 — carvedilol, hypertension, liver cirrhosis, fibrosis, liver, hypertension, portal, child | Phase 3 | Not yet recruiting | 2025 |
LeadR Networks
Main global connection map